cilengitide has been researched along with mk-0429 in 1 studies
Studies (cilengitide) | Trials (cilengitide) | Recent Studies (post-2010) (cilengitide) | Studies (mk-0429) | Trials (mk-0429) | Recent Studies (post-2010) (mk-0429) |
---|---|---|---|---|---|
194 | 29 | 133 | 6 | 0 | 2 |
Protein | Taxonomy | cilengitide (IC50) | mk-0429 (IC50) |
---|---|---|---|
Integrin beta-3 | Homo sapiens (human) | 0.1627 | |
Integrin beta-1 | Homo sapiens (human) | 2.5367 | |
Integrin alpha-V | Homo sapiens (human) | 0.1627 | |
Integrin alpha-5 | Homo sapiens (human) | 2.5367 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, JG; Babij, P; Fotsch, C | 1 |
1 review(s) available for cilengitide and mk-0429
Article | Year |
---|---|
Emerging targets in osteoporosis disease modification.
Topics: Animals; Biomarkers; Bone Density; Bone Resorption; Humans; Osteoporosis | 2010 |